Loading...
Successful Treatment of a Bullous Pemphigoid Patient with Rituximab Who Was Refractory to Corticosteroid and Omalizumab Treatments
Omalizumab is a humanized monoclonal antibody which is an FDA-approved treatment of severe allergic asthma and inhibits IgE binding to FcεRI. According to increasing evidence of IgE inhibition, omalizumab was suggested as a therapeutic approach for bullous pemphigoid (BP). Rituximab has been reporte...
Na minha lista:
| Udgivet i: | Case Rep Dermatol |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
S. Karger AG
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5346946/ https://ncbi.nlm.nih.gov/pubmed/28413387 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000452828 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|